Originally published by our sister publication, Pain Medicine News
By Inayah Entzminger
Botulinum toxin appears to be an efficacious and safe option for treating chronic pain associated with myofascial trigger points, a retrospective cohort study concluded.
Typically consisting of 0.25% levobupivacaine, ropivacaine or similar anesthetic in combination with a steroid (Methods Find Exp Clin Pharmacol 2007;29[5]:353-357; J Pain Palliat Care Pharmacother 2016;30[4]:269-275), use as a steroidal trigger